Has Paul Sponseller, MD received payments from drug or device companies?

Yes. Drug and device makers reported $957,718 in general payments to Paul Sponseller, MD across 131 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Paul Sponseller, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Paul Sponseller, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Paul Sponseller, MD

Orthopaedic Surgery · Baltimore, MDNPI 1518994037

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $848,430 of the $957,718 with a category attached, or 88.6%. Depuy Synthes Products, Inc. accounts for 67.8% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $357,000 and has fallen 91.3% since, to $30,946 in 2025. Among orthopaedic surgery clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$957,718in general payments, 2019–2025

Across 131 payments — averaging $7310.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Depuy Synthes Products, Inc.$649K
Globus Medical$216K
Medical Device Business Services, Inc.$63K
Orthopediatrics Corp.$16K
AstraZeneca$7K
Pacira Pharmaceuticals Incorporated$6K
plus $844 from 5 others

$501,279in research payments, 2019–2025

Across 25 payments — averaging $20,051 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Stryker$239K
Ipsen Biopharmaceuticals, Inc$217K
Medical Device Business Services, Inc.$46K

What the payments were for

Royalty or licence$848,43089%
Consulting fees$100,42310%
Speaking & faculty fees$4,9001%
Travel & lodging$1,9930%
Food & beverage$1,9730%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Depuy Synthes Products, Inc.	4	$649,020
Globus Medical(2 entities)	76	$215,564
Medical Device Business Services, Inc.	27	$63,434
Orthopediatrics Corp.	10	$15,716
AstraZeneca	1	$7,380
Pacira Pharmaceuticals Incorporated	1	$5,760
Zimvie Inc.	6	$509
Smith+Nephew	1	$121
Medtronic	2	$105
Stryker	2	$91
Ipsen Biopharmaceuticals, Inc	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VIPER$674,557
REFLECT$85,587
REVERE Anterior$53,116
REFLECT/REFLECT HDE$43,385
EXPEDIUM$26,661
REVERE$8,950
MAGEC$7,200
EXPAREL$5,760
REVERE 4.5$3,188
Orthopediatric Implants$3,080
MAGEC Spinal Bracing and Distraction System$2,528
Marvel Growing Rod$1,909
MARVEL$1,749
REVERE 5.5 Deformity$1,382
REVERE ADDITION$646
Prod Dev: Trauma & Deformity$625
GROWING RODS$450
ELSA$450
The Tether$278
CONDUIT$215

How this compares

$957,718 in reported general payments places this provider in the 95th percentile of 378 orthopaedic surgery providers in Maryland.

See all orthopaedic surgery providers in Maryland →

Medicare billing

Part B allowed, 2024

$13,193

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in Baltimore

Mark MyersonBaltimore$10.5M
Anand MurthiBaltimore$3.7M
Khaled KebaishBaltimore$3M
Shawn StandardBaltimore$1.4M
John HerzenbergBaltimore$746K
Leslie MatthewsBaltimore$710K
Rebecca CerratoBaltimore$575K
Henry BoucherBaltimore$315K
James WoodBaltimore$266K
Michael JacobsBaltimore$249K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →